| Dr Craig Stephen Nairn, MD | |
|
8080 Academy Rd Ne, Suite A, Albuquerque, NM 87111-1159 | |
| (505) 247-9700 | |
| (505) 247-4333 |
| Full Name | Dr Craig Stephen Nairn |
|---|---|
| Gender | Male |
| Speciality | Interventional Pain Management |
| Experience | 32 Years |
| Location | 8080 Academy Rd Ne, Albuquerque, New Mexico |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669495834 | NPI | - | NPPES |
| Q7223 | Medicaid | NM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0014X | Pain Medicine - Interventional Pain Medicine | 98348 (New Mexico) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lovelace Medical Center | Albuquerque, NM | Hospital |
| Lovelace Women's Hospital | Albuquerque, NM | Hospital |
| Lovelace Westside Hospital | Albuquerque, NM | Hospital |
| Entity Name | Pain Solutions Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205014693 PECOS PAC ID: 2062409881 Enrollment ID: O20040426001061 |
News Archive
The worldwide spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes COVID-19 infection in early 2020 prompted many nations to close their borders and institute mandatory lockdowns. While lockdowns abruptly stopped daily life, researchers from the University College London and the University of Sheffield found drug-seeking behaviors did not.
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) filed by Mallinckrodt Inc., a subsidiary of Covidien plc, for the 32 mg dose strength of EXALGO (hydromorphone HCl) Extended-Release Tablets (CII), for the management of moderate to severe pain in opioid-tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.
SPIN (SPermidin and eugenol INtegrator for contrasting incidence of coronavirus in EU population) is a European project powered by EIT Food that is currently developing a dietary supplement supporting the function of the immune system in the fight against SARS-CoV-2 infections in population at high risk.
From June 2010, Springer will publish Updates in Surgery, the official journal of the Italian Society of Surgery. The journal, previously a bilingual Italian-English publication, is now published four times a year in English only. The content will be available in print for the society members and it will also be electronically available on Springer's platform www.springerlink.com.
› Verified 6 days ago
| Entity Name | Lovelace Unm Rehabilitation Hospital, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700325677 PECOS PAC ID: 5799061917 Enrollment ID: O20170424000991 |
News Archive
The worldwide spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes COVID-19 infection in early 2020 prompted many nations to close their borders and institute mandatory lockdowns. While lockdowns abruptly stopped daily life, researchers from the University College London and the University of Sheffield found drug-seeking behaviors did not.
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) filed by Mallinckrodt Inc., a subsidiary of Covidien plc, for the 32 mg dose strength of EXALGO (hydromorphone HCl) Extended-Release Tablets (CII), for the management of moderate to severe pain in opioid-tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.
SPIN (SPermidin and eugenol INtegrator for contrasting incidence of coronavirus in EU population) is a European project powered by EIT Food that is currently developing a dietary supplement supporting the function of the immune system in the fight against SARS-CoV-2 infections in population at high risk.
From June 2010, Springer will publish Updates in Surgery, the official journal of the Italian Society of Surgery. The journal, previously a bilingual Italian-English publication, is now published four times a year in English only. The content will be available in print for the society members and it will also be electronically available on Springer's platform www.springerlink.com.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Craig Stephen Nairn, MD 8080 Academy Rd Ne, Suite A, Albuquerque, NM 87111-1159 Ph: (505) 247-9700 | Dr Craig Stephen Nairn, MD 8080 Academy Rd Ne, Suite A, Albuquerque, NM 87111-1159 Ph: (505) 247-9700 |
News Archive
The worldwide spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes COVID-19 infection in early 2020 prompted many nations to close their borders and institute mandatory lockdowns. While lockdowns abruptly stopped daily life, researchers from the University College London and the University of Sheffield found drug-seeking behaviors did not.
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) filed by Mallinckrodt Inc., a subsidiary of Covidien plc, for the 32 mg dose strength of EXALGO (hydromorphone HCl) Extended-Release Tablets (CII), for the management of moderate to severe pain in opioid-tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.
SPIN (SPermidin and eugenol INtegrator for contrasting incidence of coronavirus in EU population) is a European project powered by EIT Food that is currently developing a dietary supplement supporting the function of the immune system in the fight against SARS-CoV-2 infections in population at high risk.
From June 2010, Springer will publish Updates in Surgery, the official journal of the Italian Society of Surgery. The journal, previously a bilingual Italian-English publication, is now published four times a year in English only. The content will be available in print for the society members and it will also be electronically available on Springer's platform www.springerlink.com.
› Verified 6 days ago
Matthew Steven Bergsten, M.D. Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 3600 Coors Blvd Nw Ste 200, Albuquerque, NM 87120 Phone: 575-395-7246 | |
Timothy Earl Hansen, D.O. Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 3860 Masthead St Ne, Albuquerque, NM 87109 Phone: 505-828-1010 Fax: 505-796-9051 | |
John A Campa Iii, MD Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 7520 Montgomery Blvd Ne Bldg E4, Albuquerque, NM 87109 Phone: 505-508-1543 Fax: 505-554-2118 |